SELLAS Life Sciences Group Inc SLS Balance Sheet

Income Statement

Quarter End	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	20.94M	29.1M	18.57M	8.09M	6.22M	24.43M	15.12M	26.51M
Total Current Assets	17.76M	26.02M	15.58M	5.2M	3.17M	21.5M	12.3M	24.04M
Cash and Equivalents	17.13M	23.9M	13.81M	3.97M	2.53M	18.42M	9.15M	21.03M
Total Non-Current Assets	3.19M	3.08M	2.99M	2.88M	3.05M	2.93M	2.82M	2.47M
Total Liabilities	16.09M	15.94M	13.72M	11.91M	14.2M	14.75M	12.21M	10.61M
Total Current Liabilities	15.52M	15.51M	13.42M	11.74M	13.74M	14.44M	12.05M	10.61M
Total Non-Current Liabilities	577k	424k	302k	178k	460k	313k	161k	0
Common Equity	2k	3k	3k	3k	3k	5k	5k	6k
Retained Earnings	-179.9M	-191M	-199.84M	-209.11M	-217.24M	-226.81M	-234.28M	-241.39M

Year End December 30 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	65.81M	33.53M	16.92M	16.61M	46.05M	26.28M	20.94M	6.22M
Total Current Assets	37.5M	13.09M	5.84M	8.24M	36.93M	23.04M	17.76M	3.17M
Cash and Equivalents	18.08M	2.32M	5.34M	7.28M	35.3M	21.36M	17.13M	2.53M
Total Non-Current Assets	28.66M	2.07M	5.25M	6.09M	27.96M	20.35M	4.85M	-7.98M
Total Liabilities	37.15M	31.46M	11.67M	10.52M	18.09M	5.93M	16.09M	14.2M
Total Current Liabilities	30.4M	24.57M	5.97M	5.29M	12.34M	4.98M	15.52M	13.74M
Total Non-Current Liabilities	6.76M	9.5M	5.7M	5.23M	5.75M	946k	577k	460k
Total Equity	28.66M	2.07M	5.25M	6.09M	27.96M	20.35M	4.85M	-7.98M
Common Equity	15k	1,000	2k	5k	1,000	2k	2k	3k
Retained Earnings	-302.93M	-54.19M	-81.86M	-101.15M	-117.9M	-138.6M	-179.9M	-217.24M